Li Hua Zheng
Founder at AnHeart Therapeutics (Hangzhou) Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bing Yan | M | - |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | 6 years |
| Jun Yuan Wang | M | 51 |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | 6 years |
| Peter Traber | M | 69 |
Baylor College of Medicine
| 21 years |
| John Vierling | M | 78 |
Baylor College of Medicine
| 19 years |
| Raymond Sawaya | M | - |
Baylor College of Medicine
| 19 years |
| Xiao Hang Tong | M | 41 |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | - |
| Juan Vera | M | 44 |
Baylor College of Medicine
| 20 years |
| Zheng Wei Zhu | M | 50 |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | - |
| Xu Wei | M | - |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brett C. Sweet | M | - |
Baylor College of Medicine
| 4 years |
| Stanley H. Appel | M | - |
Baylor College of Medicine
| 27 years |
| Norman Michael Greenberg | M | 64 |
Baylor College of Medicine
| 5 years |
| Jannapureddy Madhu | M | - |
Baylor College of Medicine
| 4 years |
| Shuo Dong | M | 60 |
Baylor College of Medicine
| 11 years |
| Kyu Hyung Ha | M | - |
Fordham University School of Law
| 3 years |
| Ariel Choi | F | - |
Fordham University School of Law
| 3 years |
| Christopher Santopolo | M | - |
Fordham University School of Law
| 3 years |
| Faris Elrabie | M | - |
Fordham University School of Law
| 3 years |
| An Kang Li | M | 47 |
Baylor College of Medicine
| 3 years |
| Nicole Conner | F | - |
Fordham University School of Law
| 3 years |
| Ada Ester Giovanna Villa | F | 47 |
Fordham University School of Law
| 3 years |
| Qing Yang | F | 41 |
Fordham University School of Law
| 3 years |
| Aaron Foster | M | 52 |
Baylor College of Medicine
| 8 years |
| Ronald A. Morton | M | 65 |
Baylor College of Medicine
| 9 years |
| Benjamin Magleby | M | - |
Fordham University School of Law
| 3 years |
| Annie Dean | F | - |
Fordham University School of Law
| 3 years |
| Scott Birnbaum | M | - |
Fordham University School of Law
| 3 years |
| Emily Yudofsky | F | - |
Baylor College of Medicine
| 1 years |
| Charmaine Chan | M | - |
Baylor College of Medicine
| - |
| Wayne Riley | M | 64 |
Baylor College of Medicine
| 6 years |
| Dianne K. McKeever | F | 46 |
Fordham University School of Law
| 4 years |
| Ralph D. Feigin | M | - |
Baylor College of Medicine
| 7 years |
| Donna R. Rill | F | 70 |
Baylor College of Medicine
| 6 years |
| Charles M. Strother | M | 84 |
Baylor College of Medicine
| 3 years |
| Anup Parikh | M | - |
Baylor College of Medicine
| 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 30 | 85.71% |
| China | 5 | 14.29% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Li Hua Zheng
- Personal Network
